These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33831793)

  • 1. Cost-Effective Analysis of the Congenital Hypothyroidism Screening Program in Sri Lanka.
    Karunarathna N; Hettiarachchi M
    Value Health Reg Issues; 2021 May; 24():181-186. PubMed ID: 33831793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indicators of newborn screening for congenital hypothyroidism in Sri Lanka: program challenges and way forward.
    Hettiarachchi M; Amarasena S
    BMC Health Serv Res; 2014 Sep; 14():385. PubMed ID: 25212576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and Economic Cost of Disease Burden Due to Congenital Hypothyroidism in India: Too Little, but Not Too Late.
    Vidavalur R
    Front Pediatr; 2022; 10():788589. PubMed ID: 35592841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program.
    Lanting CI; van Tijn DA; Loeber JG; Vulsma T; de Vijlder JJ; Verkerk PH
    Pediatrics; 2005 Jul; 116(1):168-73. PubMed ID: 15995048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for congenital hypothyroidism: a worldwide view of strategies.
    Ford G; LaFranchi SH
    Best Pract Res Clin Endocrinol Metab; 2014 Mar; 28(2):175-87. PubMed ID: 24629860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.
    Knowles R; Griebsch I; Dezateux C; Brown J; Bull C; Wren C
    Health Technol Assess; 2005 Nov; 9(44):1-152, iii-iv. PubMed ID: 16297355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn hearing screening: the great omission.
    Mehl AL; Thomson V
    Pediatrics; 1998 Jan; 101(1):E4. PubMed ID: 9417168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism.
    Appelberg K; Sörensen L; Zetterström RH; Henriksson M; Wedell A; Levin LÅ
    J Pediatr; 2023 May; 256():38-43.e3. PubMed ID: 36495999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
    Gu X; Wang J; Ye J; Cheng X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):147-9. PubMed ID: 11860921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audit of the Congenital Hypothyroidism Screening Program in 15 Provinces of Iran.
    Mehran L; Yarahmadi S; Khalili D; Hedayati M; Amouzegar A; Mousapour P; Ajang N; Azizi F
    Arch Iran Med; 2019 Jun; 22(6):310-317. PubMed ID: 31356097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirty years of the newborn screening program in Central Serbia: the missed cases of congenital hypothyroidism.
    Milenkovic T; Vukovic R; Radojicic B; Mitrovic K; Todorovic S; Zatezalo L
    Turk J Pediatr; 2019; 61(3):319-324. PubMed ID: 31916707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of current guthrie TSH cut-off point in Iran congenital hypothyroidism screening program: a cost-effectiveness analysis.
    Shamshiri AR; Yarahmadi S; Forouzanfar MH; Haghdoost AA; Hamzehloo G; Holakouie Naieni K
    Arch Iran Med; 2012 Mar; 15(3):136-41. PubMed ID: 22369300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projected cost-effectiveness of statewide universal newborn hearing screening.
    Keren R; Helfand M; Homer C; McPhillips H; Lieu TA
    Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn Screening for Congenital Hypothyroidism: the Benefit of Using Differential TSH Cutoffs in a 2-Screen Program.
    Caiulo S; Corbetta C; Di Frenna M; Medda E; De Angelis S; Rotondi D; Vincenzi G; de Filippis T; Patricelli MG; Persani L; Barera G; Weber G; Olivieri A; Vigone MC
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e338-e349. PubMed ID: 33124651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: Benefits and costs of a successful public health program].
    Van Vliet G; Grosse SD
    Med Sci (Paris); 2021 May; 37(5):528-534. PubMed ID: 34003099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for PKU and congenital hypothyroidism in Latvia.
    Lugovska R; Vevere P; Andrusaite R; Kornejeva A
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():52-3. PubMed ID: 11400783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
    Geelhoed EA; Lewis B; Hounsome D; O'leary P
    J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal screening for congenital hypothyroidism.
    Torresani T
    Endocr Dev; 2014; 26():44-9. PubMed ID: 25231443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting congenital hypothyroidism with newborn screening: the relevance of thyroid-stimulating hormone cutoff values.
    Silvestrin SM; Leone C; Leone CR
    J Pediatr (Rio J); 2017; 93(3):274-280. PubMed ID: 28024960
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.